Physician profile
Rory Young
NPI 1285212894
$3,047.02
in general payments reported to CMS, 2019-2025
10 companies · $2,307 in 2025
The $2,307 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $314 · 2024: $425 · 2025: $2,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.47 |
| Travel and Lodging | $1,190.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,756.47 | 2025 | Inspire |
| Axogen | $318.02 | 2025 | |
| Stryker Corporation | $313.76 | 2023-2025 | Na, Vsp System, Vsp Cranial, Adherus Autospray Dural Sealant |
| Medtronic, INC. | $146.46 | 2024 | Stealthstation S8 Platform |
| Med-El Corporation | $136.37 | 2023 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Regeneron Healthcare Solutions, INC. | $127.65 | 2024 | Dupixent |
| Baxter Healthcare | $109.21 | 2025 | Floseal |
| Polynovo North America LLC | $83.37 | 2024 | Novosorb Btm |
| Acclarent, INC | $33.57 | 2024 | Trudi Nav Cable |
| Merck Sharp & Dohme LLC | $22.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rory Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.